TORONTO, Nov. 6 /CNW/ - ARIUS Research Inc., (TSX: ARI - News), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that Dr. David S. Young, President and Chief Executive Officer of the Company, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. Dr. Young will provide an update on the Company’s three lead anti-cancer antibody programs targeting CD44, Trop-2 and CD59.
